The effect of untargeted naloxone distribution on opioid overdose outcomes

被引:0
|
作者
Dowd, William N. [1 ,2 ]
机构
[1] RTI Int, Publ Hlth Div, Res Triangle Pk, NC 27709 USA
[2] Univ Lancaster, Div Hlth Res, Lancaster, England
关键词
harm reduction; naloxone; opioid overdose; public health; TAKE-HOME NALOXONE; UNITED-STATES; ACCESS LAWS; DEATHS; HEROIN;
D O I
10.1002/hec.4755
中图分类号
F [经济];
学科分类号
02 ;
摘要
Opioid overdose has claimed the lives of over 340,000 Americans in the last decade. Over that same period, policymakers have taken steps to increase the availability of naloxone-an opioid antagonist used to rescue overdose victims-to people in the community. Previous studies, most of which have examined the effects of state laws designed to facilitate access to naloxone, have reached mixed conclusions about the effects of naloxone access on fatal and non-fatal overdoses. This paper exploits a unique policy experiment provided by two naloxone giveaways intended to increase naloxone possession among the general public in Pennsylvania to estimate the causal impact of naloxone distribution on fatal overdoses and opioid-related emergency department (ED) visits. Using a difference-in-differences design, I find evidence that opioid overdose deaths fell immediately following the first giveaway but increased following the second giveaway and discuss these apparently contradictory findings in the context of the changing composition of the opioid supply. I also find some evidence of a decline in opioid overdose-related ED visits following the giveaways. This study is the first to examine the effects of untargeted naloxone distribution and has implications for other novel, naloxone distribution efforts currently underway.
引用
收藏
页码:2801 / 2818
页数:18
相关论文
共 50 条
  • [21] Emergency naloxone for heroin overdose - Naloxone is not the only opioid antagonist
    Brewer, Colin
    [J]. BRITISH MEDICAL JOURNAL, 2006, 333 (7571): : 754 - 755
  • [22] OPIOID OVERDOSE RISK SCREENING TOOL IMPLEMENTATION IN THE ED TO PROMOTE NALOXONE DISTRIBUTION
    Lofy, Thomas
    Feldman, Ryan
    Stanton, Matthew
    Zosel, Amy
    Chinn, Matthew
    Dora-Laskey, Aaron
    Bialkowski, Kristin
    Owen, Julie
    Hernandez-Meier, Jennifer
    Jones, Amanda
    Peppard, William
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [23] Naloxone for Opioid Overdose 101 Online Training
    Teemant, Kelly
    Moss, Michael
    Crouch, Barbara
    Bennett, Heather
    Prebish, Amelia
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1232 - 1233
  • [24] Naloxone use following oral opioid overdose
    Rhyee, Sean H.
    Carey, Jennifer L.
    [J]. CLINICAL TOXICOLOGY, 2013, 51 (07) : 614 - 614
  • [25] Intravenous bolus or infusion of naloxone in opioid overdose
    Clarke, S
    Dargan, P
    [J]. EMERGENCY MEDICINE JOURNAL, 2002, 19 (03) : 249 - 250
  • [26] Take home naloxone in opioid overdose survivors
    Morales, Elena
    Willhite, Laurie
    Olives, Travis
    Weber, Lynn
    [J]. CLINICAL TOXICOLOGY, 2019, 57 (10) : 1017 - 1018
  • [27] Pulmonary Complications of Opioid Overdose Treated With Naloxone
    Farkas, Andrew
    Lynch, Michael J.
    Westover, Rachael
    Giles, Joseph
    Siripong, Nalyn
    Nalatwad, Akanksha
    Pizon, Anthony F.
    Martin-Gill, Christian
    [J]. ANNALS OF EMERGENCY MEDICINE, 2020, 75 (01) : 39 - 48
  • [28] Managing opioid overdose in pregnancy with nasal naloxone
    Bonomo, Yvonnenh
    Pastor, Adam
    Leung, Laura
    Blandthorn, Julie
    Dietze, Paul
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2020, 60 (05): : E11 - E12
  • [29] Intranasal naloxone administration for treatment of opioid overdose
    Robinson, Amanda
    Wermeling, Daniel P.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (24) : 2129 - 2135
  • [30] Intravenous or intramuscular/subcutaneous naloxone in opioid overdose
    Clarke, S
    Dargan, P
    [J]. EMERGENCY MEDICINE JOURNAL, 2002, 19 (03) : 249 - 249